Determinants of the release pattern of ischaemia-modified albumin in acute ST-elevation myocardial infarction treated with primary PCI

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue 4, 2010, Pages 244-251

  Hjortshøj, Søren ^a   Dethlefsen, Claus ^a   Kristensen, Søren Risom ^a   Ravkilde, Jan ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute coronary syndrome; Cardiac biomarkers; Cardiology; Ischaemia; Ischaemia modified albumin; Myocardial infarction; Troponins

Indexed keywords

CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; ISCHEMIA MODIFIED ALBUMIN; MYOGLOBIN; TROPONIN T;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RATING SCALE; SEX; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADULT; AGED; ANGIOPLASTY; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; SERUM ALBUMIN;

EID: 77953866744     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365511003716990     Document Type: Article

References (42)

1. Bar-Or D, Lau E, Rao N, Bampos N, Winkler JV, Curtis CG. Reduction in the cobalt binding capacity of human albumin with myocardial ischemia. Ann Emerg Med 1999;34 (4 Suppl.): S56 (Abstract).
2. Bar-Or D, Lau E, Winkler JV. A novel assay for cobaltalbumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 2000; 19:311-315
3. Bar-Or D, Rael LT, Bar-Or R, Slone DS, Mains CW, Rao NK, Curtis CG. The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 2008;387:120-127
4. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2+ ) and Ni(2+ ) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001;268:42-47
5. Abadie JM, Blassingame CL, Bankson DD. Albumin cobalt binding assay to rule out acute coronary syndrome. Ann Clin Lab Sci 2005;35:66-72.
6. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-470
7. Collinson PO, Gaze DC, Bainbridge K, Morris F, Morris B, Price A, Goodacre S. Utility of admission cardiac troponin and ' Ischemia Modified Albumin ' measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 2006; 23:256-261
8. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo- Espliguero R, Gaze D, Collinson P, Carlos KJ. Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004;97: 297-301.
9. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of ' Ischemia modified albumin ' , a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
10. Wu AH, Morris DL, Fletcher DR, Apple FS, Christenson RH, Painter PC. Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol 2001;1:147-151
11. Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller- Geiger D, Pollack CV. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006;152:253-262
12. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985-991
13. Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, Quiles J, Gaze DC, Kaski JC. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 2004;93:88-90.
14. Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, Kaski JC. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 2003;92:322-324
15. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006;92:113-114
16. Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. High ischemia-modified albumin concentration refl ects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 2004;50:2190-2193
17. Can M, Demirtas S, Polat O, Yildiz A. Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma. Emerg Med J 2006;23:537-539
18. Falkensammer J, Stojakovic T, Huber K, Hammerer-Lercher A, Gruber I, Scharnagl H, Fraedrich G, Santner W, Schocke M, Greiner A. Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia. Clin Chem Lab Med 2007;45:535-540
19. Roy D, Quiles J, Sinha M, Floros D, Gaze D, Collinson P, Baxter GF, Kaski JC. Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin. Am J Cardiol 2004;94:234-236
20. Roy D, Quiles J, Sinha M, Aldama G, Gaze D, Kaski JC. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fi brillation. Am J Cardiol 2004;93:366-368
21. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002; 48:1097-1100
22. Troxler M, Thompson D, Homer-Vanniasinkam S. Ischaemic skeletal muscle increases serum ischaemia modified albumin. Eur J Vasc Endovasc Surg 2006;31:164-169
23. Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, Mazighi M, Dehoux M, Benessiano J, Steg PG, Amarenco P. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007;23:216-220
24. Hjortshoj S, Kristensen SR, Ravkilde J. Diagnostic value of Ischemia Modified Albumin in patients with suspected acute coronary syndrome. Am J Emerg Medicine 2010;28:170-176
25. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefi nition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144: 981-986
26. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, Mair J, Ravkilde J, Wu AH. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-332
27. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003;49:1331-1336
28. Pelsers MM, Chapelle JP, Knapen M, Vermeer C, Muijtjens AM, Hermens WT, Glatz JF. Infl uence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clin Chem 1999;45:441-443
29. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847 (Pubitemid 40547082)
30. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985; 312:932-936
31. Sinha MK, Vazquez JM, Calvino R, Gaze DC, Collinson PO, Kaski JC. Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction. Heart 2006;92:1852-1853
32. Jurlander B, Clemmensen P, Ohman EM, Christenson R, Wagner GS, Grande P. Serum myoglobin for the early non-invasive detection of coronary reperfusion in patients with acute myocardial infarction. Eur Heart J 1996;17: 399-406.
33. Haastrup B, Gill S, Haghfelt T, Horder M, Kristensen SR. Dependency on infarct size limits the clinical applicability of non-invasive reperfusion assessment by biochemical markers in acute myocardial infarction. Heart Drug 2001; 1:197-206.
34. de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the effi cacy of reperfusion therapy. J Am Coll Cardiol 2001;38:1283-1294
35. Jurlander B, Holmvang L, Galatius S, Vaught C, Johanson P, Krucoff MW, Grande P, Clemmensen P, Wagner GS. ' Mirror-lake ' serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction. Am Heart J 2003;146:757-763
36. Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, Mazighi M, Dehoux M, Benessiano J, Steg PG, Amarenco P. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2006;23:216-220
37. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, Topbas M, Aydin M, Eraydin I, Akcan B. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008;26:874-878
38. Gunduz A, Turkmen S, Turedi S, Mentese A, Yulug E, Ulusoy H, Karahan SC, Topbas M. Time-dependent variations in ischemia-modified albumin levels in mesenteric ischemia. Acad Emerg Med 2009;16:539-543
39. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Kaski JC. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004;50:1656-1660
40. Turedi S, Gunduz A, Mentese A, Karahan SC, Yilmaz SE, Eroglu O, Nuhoglu I, Turan I, Topbas M. Value of ischemiamodified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 2007;25:770-773
41. Beetham R, Monk C, Keating L, Benger JR, Kendall J. Effects of storage at -20 degrees C on ischaemia-modified albumin results. Ann Clin Biochem 2006;43:500-502
42. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS. A comparison of coronary angioplasty with fi brinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349:733-742